Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapyJ Immunother Cancer 2023 Mar 01;11(3)e006629, P Bhave, A Hong, SN Lo, R Johnson, J Mangana, DB Johnson, O Dulgar, Z Eroglu, HL Yeoh, A Haydon, GC Lodde, E Livingstone, A Khattak, K Kähler, A Hausschild, GA McArthur, AM Menzies, G Long, W Wang, MS Carlino
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.